Intellect Neurosciences Inc. (fka ILNS)

[montanus]

INTELLECT NEUROSCIENCES INCORPORATED (OTCMKTS:ILNS) Shorted Shares Increased By 6.67%
by Franklin Staff — May 6, 2016

The stock of INTELLECT NEUROSCIENCES INCORPORATED (OTCMKTS:ILNS) registered an increase of 6.67% in short interest. ILNS’s total short interest was 4,800 shares in May as published by FINRA. Its up 6.67% from 4,500 shares, reported previously. With 21,800 shares average volume, it will take short sellers 0 days to cover their ILNS’s short positions. The stock is down 2.78% or $0.002 after the news, hitting $0.07 per share. About 218,235 shares traded hands or 1284.92% up from the average. Intellect Neurosciences, Inc. (OTCMKTS:ILNS) has risen 15.94% since October 8, 2015 and is uptrending. It has outperformed by 9.14% the S&P500.

Intellect Neurosciences, Inc. is a biopharmaceutical company. The company has a market cap of $339,757. The Company, together with its subsidiary, Intellect Neurosciences, USA, Inc., is engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of neurodegenerative conditions especially proteinopathies, which include Alzheimer’s , Parkinson’s and Huntington disease. It currently has negative earnings. The Company’s internal drug discovery programs are focused on the therapeutic applications of monoclonal antibodies.

http://www.franklinindependent.com/intellect-neurosciences-incorporated-otcmktsilns-shorted-shares-increased-by-6-67/